Report cover image

Global Custom Synthetic Genes Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 199 Pages
SKU # APRC20283553

Description

Summary

According to APO Research, The global Custom Synthetic Genes market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Custom Synthetic Genes is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Custom Synthetic Genes is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Custom Synthetic Genes is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Custom Synthetic Genes is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Custom Synthetic Genes include Azenta Life Sciences, BBI, Bio Basic, DNA 2.0 (ATUM), Eurofins Genomics, Genescript, IDT, OriGene and SBS Genetech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Custom Synthetic Genes, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Custom Synthetic Genes, also provides the revenue of main regions and countries. Of the upcoming market potential for Custom Synthetic Genes, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Custom Synthetic Genes revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Custom Synthetic Genes market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Custom Synthetic Genes revenue, projected growth trends, production technology, application and end-user industry.

Custom Synthetic Genes Segment by Company

Azenta Life Sciences
BBI
Bio Basic
DNA 2.0 (ATUM)
Eurofins Genomics
Genescript
IDT
OriGene
SBS Genetech
Thermo Scientific
Twist Bioscience
Custom Synthetic Genes Segment by Type

Above 5000 bp
3001- 5000 bp
1001 - 3000 bp
Below 1000 bp
Custom Synthetic Genes Segment by Application

Commercial
Academic Research
Custom Synthetic Genes Segment by Region

North America
United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Synthetic Genes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Custom Synthetic Genes and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Synthetic Genes.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Custom Synthetic Genes in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Custom Synthetic Genes company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Custom Synthetic Genes revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

199 Pages
1 Market Overview
1.1 Product Definition
1.2 Custom Synthetic Genes Market by Type
1.2.1 Global Custom Synthetic Genes Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Above 5000 bp
1.2.3 3001- 5000 bp
1.2.4 1001 - 3000 bp
1.2.5 Below 1000 bp
1.3 Custom Synthetic Genes Market by Application
1.3.1 Global Custom Synthetic Genes Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Commercial
1.3.3 Academic Research
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Custom Synthetic Genes Market Dynamics
2.1 Custom Synthetic Genes Industry Trends
2.2 Custom Synthetic Genes Industry Drivers
2.3 Custom Synthetic Genes Industry Opportunities and Challenges
2.4 Custom Synthetic Genes Industry Restraints
3 Global Growth Perspective
3.1 Global Custom Synthetic Genes Market Perspective (2020-2031)
3.2 Global Custom Synthetic Genes Growth Trends by Region
3.2.1 Global Custom Synthetic Genes Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Custom Synthetic Genes Market Size by Region (2020-2025)
3.2.3 Global Custom Synthetic Genes Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Custom Synthetic Genes Revenue by Players
4.1.1 Global Custom Synthetic Genes Revenue by Players (2020-2025)
4.1.2 Global Custom Synthetic Genes Revenue Market Share by Players (2020-2025)
4.1.3 Global Custom Synthetic Genes Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Custom Synthetic Genes Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Custom Synthetic Genes Key Players Headquarters & Area Served
4.4 Global Custom Synthetic Genes Players, Product Type & Application
4.5 Global Custom Synthetic Genes Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Custom Synthetic Genes Market CR5 and HHI
4.6.3 2024 Custom Synthetic Genes Tier 1, Tier 2, and Tier 3
5 Custom Synthetic Genes Market Size by Type
5.1 Global Custom Synthetic Genes Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Custom Synthetic Genes Revenue by Type (2020-2031)
5.3 Global Custom Synthetic Genes Revenue Market Share by Type (2020-2031)
6 Custom Synthetic Genes Market Size by Application
6.1 Global Custom Synthetic Genes Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Custom Synthetic Genes Revenue by Application (2020-2031)
6.3 Global Custom Synthetic Genes Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Azenta Life Sciences
7.1.1 Azenta Life Sciences Comapny Information
7.1.2 Azenta Life Sciences Business Overview
7.1.3 Azenta Life Sciences Custom Synthetic Genes Revenue and Gross Margin (2020-2025)
7.1.4 Azenta Life Sciences Custom Synthetic Genes Product Portfolio
7.1.5 Azenta Life Sciences Recent Developments
7.2 BBI
7.2.1 BBI Comapny Information
7.2.2 BBI Business Overview
7.2.3 BBI Custom Synthetic Genes Revenue and Gross Margin (2020-2025)
7.2.4 BBI Custom Synthetic Genes Product Portfolio
7.2.5 BBI Recent Developments
7.3 Bio Basic
7.3.1 Bio Basic Comapny Information
7.3.2 Bio Basic Business Overview
7.3.3 Bio Basic Custom Synthetic Genes Revenue and Gross Margin (2020-2025)
7.3.4 Bio Basic Custom Synthetic Genes Product Portfolio
7.3.5 Bio Basic Recent Developments
7.4 DNA 2.0 (ATUM)
7.4.1 DNA 2.0 (ATUM) Comapny Information
7.4.2 DNA 2.0 (ATUM) Business Overview
7.4.3 DNA 2.0 (ATUM) Custom Synthetic Genes Revenue and Gross Margin (2020-2025)
7.4.4 DNA 2.0 (ATUM) Custom Synthetic Genes Product Portfolio
7.4.5 DNA 2.0 (ATUM) Recent Developments
7.5 Eurofins Genomics
7.5.1 Eurofins Genomics Comapny Information
7.5.2 Eurofins Genomics Business Overview
7.5.3 Eurofins Genomics Custom Synthetic Genes Revenue and Gross Margin (2020-2025)
7.5.4 Eurofins Genomics Custom Synthetic Genes Product Portfolio
7.5.5 Eurofins Genomics Recent Developments
7.6 Genescript
7.6.1 Genescript Comapny Information
7.6.2 Genescript Business Overview
7.6.3 Genescript Custom Synthetic Genes Revenue and Gross Margin (2020-2025)
7.6.4 Genescript Custom Synthetic Genes Product Portfolio
7.6.5 Genescript Recent Developments
7.7 IDT
7.7.1 IDT Comapny Information
7.7.2 IDT Business Overview
7.7.3 IDT Custom Synthetic Genes Revenue and Gross Margin (2020-2025)
7.7.4 IDT Custom Synthetic Genes Product Portfolio
7.7.5 IDT Recent Developments
7.8 OriGene
7.8.1 OriGene Comapny Information
7.8.2 OriGene Business Overview
7.8.3 OriGene Custom Synthetic Genes Revenue and Gross Margin (2020-2025)
7.8.4 OriGene Custom Synthetic Genes Product Portfolio
7.8.5 OriGene Recent Developments
7.9 SBS Genetech
7.9.1 SBS Genetech Comapny Information
7.9.2 SBS Genetech Business Overview
7.9.3 SBS Genetech Custom Synthetic Genes Revenue and Gross Margin (2020-2025)
7.9.4 SBS Genetech Custom Synthetic Genes Product Portfolio
7.9.5 SBS Genetech Recent Developments
7.10 Thermo Scientific
7.10.1 Thermo Scientific Comapny Information
7.10.2 Thermo Scientific Business Overview
7.10.3 Thermo Scientific Custom Synthetic Genes Revenue and Gross Margin (2020-2025)
7.10.4 Thermo Scientific Custom Synthetic Genes Product Portfolio
7.10.5 Thermo Scientific Recent Developments
7.11 Twist Bioscience
7.11.1 Twist Bioscience Comapny Information
7.11.2 Twist Bioscience Business Overview
7.11.3 Twist Bioscience Custom Synthetic Genes Revenue and Gross Margin (2020-2025)
7.11.4 Twist Bioscience Custom Synthetic Genes Product Portfolio
7.11.5 Twist Bioscience Recent Developments
8 North America
8.1 North America Custom Synthetic Genes Revenue (2020-2031)
8.2 North America Custom Synthetic Genes Revenue by Type (2020-2031)
8.2.1 North America Custom Synthetic Genes Revenue by Type (2020-2025)
8.2.2 North America Custom Synthetic Genes Revenue by Type (2026-2031)
8.3 North America Custom Synthetic Genes Revenue Share by Type (2020-2031)
8.4 North America Custom Synthetic Genes Revenue by Application (2020-2031)
8.4.1 North America Custom Synthetic Genes Revenue by Application (2020-2025)
8.4.2 North America Custom Synthetic Genes Revenue by Application (2026-2031)
8.5 North America Custom Synthetic Genes Revenue Share by Application (2020-2031)
8.6 North America Custom Synthetic Genes Revenue by Country
8.6.1 North America Custom Synthetic Genes Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Custom Synthetic Genes Revenue by Country (2020-2025)
8.6.3 North America Custom Synthetic Genes Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe Custom Synthetic Genes Revenue (2020-2031)
9.2 Europe Custom Synthetic Genes Revenue by Type (2020-2031)
9.2.1 Europe Custom Synthetic Genes Revenue by Type (2020-2025)
9.2.2 Europe Custom Synthetic Genes Revenue by Type (2026-2031)
9.3 Europe Custom Synthetic Genes Revenue Share by Type (2020-2031)
9.4 Europe Custom Synthetic Genes Revenue by Application (2020-2031)
9.4.1 Europe Custom Synthetic Genes Revenue by Application (2020-2025)
9.4.2 Europe Custom Synthetic Genes Revenue by Application (2026-2031)
9.5 Europe Custom Synthetic Genes Revenue Share by Application (2020-2031)
9.6 Europe Custom Synthetic Genes Revenue by Country
9.6.1 Europe Custom Synthetic Genes Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Custom Synthetic Genes Revenue by Country (2020-2025)
9.6.3 Europe Custom Synthetic Genes Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China Custom Synthetic Genes Revenue (2020-2031)
10.2 China Custom Synthetic Genes Revenue by Type (2020-2031)
10.2.1 China Custom Synthetic Genes Revenue by Type (2020-2025)
10.2.2 China Custom Synthetic Genes Revenue by Type (2026-2031)
10.3 China Custom Synthetic Genes Revenue Share by Type (2020-2031)
10.4 China Custom Synthetic Genes Revenue by Application (2020-2031)
10.4.1 China Custom Synthetic Genes Revenue by Application (2020-2025)
10.4.2 China Custom Synthetic Genes Revenue by Application (2026-2031)
10.5 China Custom Synthetic Genes Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Custom Synthetic Genes Revenue (2020-2031)
11.2 Asia Custom Synthetic Genes Revenue by Type (2020-2031)
11.2.1 Asia Custom Synthetic Genes Revenue by Type (2020-2025)
11.2.2 Asia Custom Synthetic Genes Revenue by Type (2026-2031)
11.3 Asia Custom Synthetic Genes Revenue Share by Type (2020-2031)
11.4 Asia Custom Synthetic Genes Revenue by Application (2020-2031)
11.4.1 Asia Custom Synthetic Genes Revenue by Application (2020-2025)
11.4.2 Asia Custom Synthetic Genes Revenue by Application (2026-2031)
11.5 Asia Custom Synthetic Genes Revenue Share by Application (2020-2031)
11.6 Asia Custom Synthetic Genes Revenue by Country
11.6.1 Asia Custom Synthetic Genes Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Custom Synthetic Genes Revenue by Country (2020-2025)
11.6.3 Asia Custom Synthetic Genes Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Custom Synthetic Genes Revenue (2020-2031)
12.2 SAMEA Custom Synthetic Genes Revenue by Type (2020-2031)
12.2.1 SAMEA Custom Synthetic Genes Revenue by Type (2020-2025)
12.2.2 SAMEA Custom Synthetic Genes Revenue by Type (2026-2031)
12.3 SAMEA Custom Synthetic Genes Revenue Share by Type (2020-2031)
12.4 SAMEA Custom Synthetic Genes Revenue by Application (2020-2031)
12.4.1 SAMEA Custom Synthetic Genes Revenue by Application (2020-2025)
12.4.2 SAMEA Custom Synthetic Genes Revenue by Application (2026-2031)
12.5 SAMEA Custom Synthetic Genes Revenue Share by Application (2020-2031)
12.6 SAMEA Custom Synthetic Genes Revenue by Country
12.6.1 SAMEA Custom Synthetic Genes Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Custom Synthetic Genes Revenue by Country (2020-2025)
12.6.3 SAMEA Custom Synthetic Genes Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.